US EditionTrump reclassifies state-licensed medical marijuana as a less-dangerous drug in a historic shift
The move lets state-licensed medical cannabis and FDA-approved products move into Schedule III, easing research barriers and tax burdens, officials said.
- On Thursday, Acting Attorney General Todd Blanche signed an order reclassifying state-licensed medical marijuana from Schedule I to Schedule III, easing research barriers and granting licensed operators federal tax deductions.
- President Donald Trump ordered his administration in December to accelerate rescheduling. Blanche stated the action was "delivering on President Trump's promise" to expand Americans' access to medical treatment options.
- The action legitimizes medical marijuana systems in 40 states, shifting away from prohibition standards dating to the Marijuana Tax Act of 1937, while non-licensed marijuana remains strictly regulated under Schedule I.
- Although the order provides tax relief, it does not legalize marijuana for recreational use. In Washington, 302 of 460 licensed stores have endorsements allowing tax-free sales to registered patients.
- More than 20 Republican senators urged the president to maintain existing standards last year, and the Justice Department plans to launch administrative hearings in June to consider broader marijuana rescheduling.
465 Articles
465 Articles
U.S. Moves Marijuana to Schedule III, Reshaping Research and the Cannabis Economy
The United States federal government reclassified state-licensed medical marijuana on Thursday, ending decades of policy that placed the drug in the same category as heroin and had long restricted its use in scientific research. The U.S. Department of Justice announced that FDA-approved cannabinoid-based medications and state-licensed medical marijuana will move from Schedule I to Schedule III under the Controlled Substances Act. This change doe…
DOJ loosens medical marijuana restrictions
What happenedThe Justice Department on Thursday reclassified marijuana as a less-dangerous Schedule III drug for medicinal and research uses, effective immediately. The order aligns federal policy more closely with the 48 states that allow some form of medical marijuana use. Who said whatThe reclassification “will make it easier to study medicinal applications of marijuana and could shore up support from influencers who support the research,” Ax…
What to Know About Trump’s Reclassification of Medical Marijuana
—Getty Images/Yuri KriventsoffOn April 23, acting U.S. attorney general Todd Blanche signed an order changing the federal classification of medical marijuana. The move, which came at the behest of President Donald Trump and will make the substance a Schedule 3 drug, will bring enormous tax benefits to medical marijuana producers in the 40 states where medical use is legal and may speed research into its effects, experts say. But it does not lega…
US reclassifies dagga in ‘pivotal moment’ but not fully legal yet
The US Department of Justice said it would immediately loosen restrictions on some marijuana products and move quickly to reclassify the drug as less dangerous, in one of the biggest changes to US drug policy in decades.
Coverage Details
Bias Distribution
- 53% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
